共 192 条
[1]
Harbeck N(2017)Neoadjuvant therapy for triple negative and HER2-positive early breast cancer Breast 34 S99-S103
[2]
Gluz O(2017)MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy Breast Cancer Res Treat 164 99-106
[3]
van Ramshorst MS(2020)Dynamic contrast-enhanced mri evaluation of pathologic complete response in human epidermal growth factor receptor 2 (HER2)-positive breast cancer after HER2-targeted therapy Acad Radiol 27 e87-93
[4]
Loo CE(2019)Magnetic resonance imaging combined with second-look ultrasonography in predicting pathologic complete response after neoadjuvant chemotherapy in primary breast cancer patients Clin Breast Cancer 19 71-77
[5]
Groen EJ(2017)Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer AJR Am J Roentgenol. 208 290-299
[6]
Winter-Warnars GH(2011)Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients Ann Surg Oncol 18 3160-3163
[7]
Wesseling J(2005)Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer AJR Am J Roentgenol 184 868-877
[8]
van Duijnhoven F(2018)MRI, clinical examination, and mammography for preoperative assessment of residual disease and pathologic complete response after neoadjuvant chemotherapy for breast cancer: ACRIN 6657 trial AJR Am J Roentgenol 210 1376-1385
[9]
Heacock L(2013)Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017 Cancer 119 1776-1783
[10]
Lewin A(2018)Discrepancies between pathological tumor responses and estimations of complete response by magnetic resonance imaging after neoadjuvant chemotherapy differ by breast cancer subtype Clin Breast Cancer 18 128-134